39 related articles for article (PubMed ID: 3261813)
1. Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS).
Masuzawa M; Masuzawa M; Hamada Y; Arakawa N; Mori M; Ishii M; Nishiyama S
Cancer Med; 2012 Aug; 1(1):39-46. PubMed ID: 23342252
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.
Akhtar N; Padilla ML; Dickerson EB; Steinberg H; Breen M; Auerbach R; Helfand SC
Neoplasia; 2004; 6(2):106-16. PubMed ID: 15140399
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antimetastatic effects of lentinan and interleukin 2 with pre- and post-operative treatments.
Hamuro J; Takatsuki F; Suga T; Kikuchi T; Suzuki M
Jpn J Cancer Res; 1994 Dec; 85(12):1288-97. PubMed ID: 7852191
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and bone marrow transplantation.
Takaku F
J Cancer Res Clin Oncol; 1995; 121(12):701-9. PubMed ID: 7499440
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of recombinant human interleukin-2 on the growth of murine hemangioendothelioma D14 in nude mice: occurrence of large granular cells in the tumor.
Sakura Y; Houkan T; Ootsu K; Shino A
Jpn J Cancer Res; 1991 Aug; 82(8):950-7. PubMed ID: 1910031
[TBL] [Abstract][Full Text] [Related]
6. Relapse after successful treatment with immunotherapy: lessons for the future.
Fisher RI
Cancer J Sci Am; 1998; 4(2):78-9. PubMed ID: 9532407
[No Abstract] [Full Text] [Related]
7. [A dramatic effect of continuous intra-arterial injected recombinant interleukin-2 immunotherapy on malignant hemangioendothelioma].
Takano M; Suzuki Y; Asai T; Masuzawa M; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):719-25. PubMed ID: 1942580
[TBL] [Abstract][Full Text] [Related]
8. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2].
Fujioka A; Sezai Y
Nihon Hifuka Gakkai Zasshi; 1991 Aug; 101(9):959-63. PubMed ID: 1942594
[TBL] [Abstract][Full Text] [Related]
9. A case of malignant haemangioendothelioma showing response to interleukin 2 therapy.
Inadomi T; Fujioka A; Suzuki H
Br J Dermatol; 1992 Oct; 127(4):442-3. PubMed ID: 1419766
[No Abstract] [Full Text] [Related]
10. Malignant angioendothelioma--effect of immunotherapy with Corynebacterium parvum.
Tan SG; Cotterill JA; Roberts MM; Cunliffe WJ
Acta Derm Venereol; 1978; 58(6):551-3. PubMed ID: 83086
[No Abstract] [Full Text] [Related]
11. Spindle cell hemangioendothelioma: successful treatment with recombinant interleukin-2.
Setoyama M; Shimada H; Miyazono N; Baba Y; Kanzaki T
Br J Dermatol; 2000 Jun; 142(6):1238-9. PubMed ID: 10848757
[No Abstract] [Full Text] [Related]
12. [Successful immunotherapy of malignant hemangioendothelioma using recombinant interleukin-2].
Masuzawa M; Higashi K; Nishioka K; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1988 Mar; 98(3):367-9. PubMed ID: 3261813
[No Abstract] [Full Text] [Related]
13. Cutaneous malignant hemangioendothelioma: clinical and histopathological observations of nine patients and a review of the literature.
Bhutto AM; Uehara K; Takamiyagi A; Hagiwara K; Nonaka S
J Dermatol; 1995 Apr; 22(4):253-61. PubMed ID: 7608382
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
